knowledge -WSS

knowledge

author：fashion 2025-09-27 09:53:33 - browse：6269

Enticed by the immense market opened by GLP-1 weight loss drugs Wegovy and Zepbound, a handful of biotech companies are trying to develop next-generation, longer-lasting therapies based on a very different approach: RNA interference.

This Nobel Prize-winning science works by degrading the biological blueprints that RNA use to make proteins — without the genetic instructions, the troublesome proteins are never made and the gene is essentially muted.

If the companies succeed, it would be a significant shift in the obesity treatment revolution, away from weekly drugs targeting hormones to medications that could be given much less frequently — twice a year or even less — and pinpoint genetic contributors to weight.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： NIH fellows want a pay raise. Will that mean less money for grants?

WSS

Living with Fabry disease, a condition that causes chronic pain

Adults seen as increasingly susceptible to measles

No plane should take off without an EpiPen onboard

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Wildfire pollution widens asthma inequities on Long Island

New research casts further doubt on a common procedure used with IVF

explore

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

Hollywood unions extend contract negotiations for actors

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

Sports medicine is finally prioritizing gender equality

New safety details link Apellis eye drug to rare cases of blindness

How one medical school became remarkably diverse

What to expect as Trump is arraigned on his Jan 6. indictment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Bright Health sells Medicare Advantage business to Molina

Adults seen as increasingly susceptible to measles

leisure time

‘Oppenheimer’ and the risks of AI in health care

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

Amazon expands telehealth clinic nationwide

New research casts further doubt on a common procedure used with IVF

Bulgari apologizes to China for listing Taiwan as a country after online backlash

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Wikipedia

hotspot

focus

focus